R Jay Mashl
5PUBLICATIONS
117CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 20, 2026
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.Tito A Sandoval, Yize Li, Naoshad Muhammad
|Jul 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.Brian S White, Xing Yi Woo, Soner Koc
|May 08, 2024
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.Zhanfang Guo, Jingqin Luo, R Jay Mashl
|Mar 21, 2024
Combined KRAS-MAPK pathway inhibitors and HER2-directed drug conjugate is efficacious in pancreatic cancer.Ashenafi Bulle, Peng Liu, Kuljeet Seehra
|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.Yige Wu, Siqi Chen, Xiaolu Yang
Pageof 1
Frequent Collaborators
5 joint publications
Li Ding
5 joint publications
Sherri R Davies
4 joint publications
Shunqiang Li
4 joint publications
Ramaswamy Govindan
3 joint publications
Jacqueline Mudd
3 joint publications
Ryan C Fields
2 joint publications
David G DeNardo
2 joint publications
Jason M Held
2 joint publications
Kian-Huat Lim
2 joint publications
Jeremy Hoog
